Integris Medtech Limited

Offer Period- – -

- – -

MainBoardUpcoming

Listed Price:

—

Price Band₹0 - ₹0

Lot Size0 Shares

Allotment Date-

Listing Date-

Subscription-

Issue Size₹0.00 Cr

Share IPO Trend

IPO Details

Subscription

Lot Distribution

Reservation

Company Fin.

₹0
(0.00%)

Premium (ELP)

Integris Medtech Limited's is preparing to launch its Initial Public Offering (IPO) with a substantial issue size of TBD. The offering comprises a fresh issue component of TBD.

The price band for the IPO has been set at TBD, providing investors with a range to place their bids. The minimum investment lot consists of TBD, making it accessible to both retail and institutional investors.

The subscription window for this public offering opens on TBD and will conclude on TBD. Following the subscription period, the share allotment is scheduled for TBD, with the official listing expected to commence on TBD on the NSE, BSE exchange.

Integris Medtech IPO Details

IPO Date

- to -

Allotment Date

List Date

Lot Size

0 share

Issue Price

₹0 - ₹0

Issue Size

Fresh Issue

Offer For Sale

Listing At

NSE, BSE

Share Holding Pre-Issue

Share Holding Post-Issue

Market Marker Portion

First time applying for an IPO? Read our guide on How to Apply for an IPO & Bidding Timings.

Integris Medtech IPO Key Performance Indicators

Learn About IPO KPIs →

KPI	Values

KPI	Values
EPS	6.52
ROE	5.35
ROCE	14.51
RONW	1.48
PRE IPO(PE)	0
POST IPO(PE)	0

Want to understand how to evaluate these metrics? Read our guide on IPO Key Performance Indicators (KPIs).

Company Financials (In Crores)

Period Ended	Jun-25	Mar-25	Mar-24	Mar-23

Period Ended	Jun-25	Mar-25	Mar-24	Mar-23
Assets	4,019.62	3,641.34	2,989.20	2,553.87
Revenue	508.93	1,959.58	1,582.26	1,369.66
Net Worth	3,889.99	2,752.52	2,681.02	2,629.52
Profit after tax	267.57	70.68	-4.88	-40.54
Reserves And Surpluse	2,299.84	1,150.74	1,135.71	1,073.12
Total Borrowing	793.42	1,729.46	813.10	556.54

Integris Medtech IPO About Company

Founded in 2008, Integris Medtech Ltd is a global medical products and laboratory solutions company based in India. It designs, manufactures, and sells a wide range of medical devices and lab equipment, focusing on cardiovascular care, diagnostics, and scientific research. With manufacturing units in India, Germany, and the Netherlands, the company serves over 65 international markets, catering to 9,500 laboratories and 2,000 hospitals. Its two main divisions include Cardiovascular Devices—offering stents, balloons, and vascular solutions—and Laboratory Solutions—providing instruments, reagents, consumables, and maintenance services under the BioCal brand. Integris Medtech operates across India, Europe, and Southeast Asia with strong brands like Chrome and Protégé, employing nearly 1,900 professionals and supporting global clinical research and patient care through innovation.

Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."

The expected premium (GMP) is based on market buzz and unofficial trading. It should not be considered as the guaranteed listing price. Always refer to the RHP and seek advice from a financial expert before making investment decisions.

💡 Read our detailed guide: What is IPO Grey Market Premium (GMP) & How It Works?•📈 Track all live rates on IPO GMP Today

✅Integris Medtech IPO Strength Factors

⚠️Integris Medtech IPO Risk Factors

👤Integris Medtech IPO Promoter(s)

Evercure Holdings Pte. Ltd.
Medicore Holdings Pte. Ltd.
Gurmit Singh Chugh
Punita Sharma

🏢Integris Medtech IPO Company Details

Integris Medtech Limited

Email:investors@integrismedtech.com

Phone:+91 120 4531422

Website:http://www.integrismedtech.com/

address:1 st Floor Metro Tower LSC M.O.R Land, New Rajinder Nagar North Delhi, New Delhi, 110060

📋Integris Medtech IPO Registrar

Kfin Technologies Limited

Name:Kfin Technologies Limited

Phone:04067162222

Email:integris.ipo@kfintech.com

Website:https://ipostatus.kfintech.com/

❓Integris Medtech IPO FAQs

Integris Medtech IPO is a main-board IPO of 0 equity shares of the face value of undefined aggregating up to ₹0.00 crore shares. The issue is priced at ₹0 - ₹0 per share. The minimum order quantity is .The IPO opens on -, and closes on -. Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE, BSE.

Zerodha customers can apply online in Integris Medtech IPO using UPI as a payment gateway. Zerodha customers can apply in Integris Medtech IPO by login into Zerodha Console (back office) and submitting an IPO application form. Steps to apply in Integris Medtech IPO through Zerodha (1) Visit the Zerodha website and login to Console. (2) Go to Portfolio and click the IPOs link. (3) Go to the 'Integris Medtech IPO' row and click the 'Bid' button. (4) Enter your UPI ID, Quantity, and Price. (5) Submit IPO application form. (6) Visit the UPI App (net banking or BHIM) to approve the mandate. Visit Zerodha IPO Application Process Review for more detail.

The Integris Medtech IPO opens on - and closes on -.

You can apply in Integris Medtech IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.

The finalization of Basis of Allotment for Integris Medtech IPO will be done on -, and the allotted shares will be credited to your demat account by -

Integris Medtech IPO's listing date is -.

Integris Medtech IPO GMP (Grey Market Premium) is the unofficial price at which IPO shares trade before listing on the stock exchange. It shows investor demand, IPO listing gain expectations, and overall IPO market sentiment. Current GMP is ₹0. Track all live rates on our IPO GMP Today tracker.

Integris Medtech Limited

IPO Details

Subscription

Lot Distribution

Reservation

Company Fin.

₹0(0.00%)

Premium (ELP)

₹0
(0.00%)